162 related articles for article (PubMed ID: 32386297)
1. HotSpotAnnotations-a database for hotspot mutations and annotations in cancer.
Trevino V
Database (Oxford); 2020 Jan; 2020():. PubMed ID: 32386297
[TBL] [Abstract][Full Text] [Related]
2. Passenger hotspot mutations in cancer driven by APOBEC3A and mesoscale genomic features.
Buisson R; Langenbucher A; Bowen D; Kwan EE; Benes CH; Zou L; Lawrence MS
Science; 2019 Jun; 364(6447):. PubMed ID: 31249028
[TBL] [Abstract][Full Text] [Related]
3. Modeling and analysis of site-specific mutations in cancer identifies known plus putative novel hotspots and bias due to contextual sequences.
Trevino V
Comput Struct Biotechnol J; 2020; 18():1664-1675. PubMed ID: 32670506
[TBL] [Abstract][Full Text] [Related]
4. Quantification of ongoing APOBEC3A activity in tumor cells by monitoring RNA editing at hotspots.
Jalili P; Bowen D; Langenbucher A; Park S; Aguirre K; Corcoran RB; Fleischman AG; Lawrence MS; Zou L; Buisson R
Nat Commun; 2020 Jun; 11(1):2971. PubMed ID: 32532990
[TBL] [Abstract][Full Text] [Related]
5. Identification of Local Clusters of Mutation Hotspots in Cancer-Related Genes and Their Biological Relevance.
Rhee JK; Yoo J; Kim KR; Kim J; Lee YJ; Chul Cho B; Kim TM
IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(5):1656-1662. PubMed ID: 29993813
[TBL] [Abstract][Full Text] [Related]
6. Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer.
Shi MJ; Meng XY; Fontugne J; Chen CL; Radvanyi F; Bernard-Pierrot I
Genome Med; 2020 Sep; 12(1):85. PubMed ID: 32988402
[TBL] [Abstract][Full Text] [Related]
7. Computational methods for detecting cancer hotspots.
Martinez-Ledesma E; Flores D; Trevino V
Comput Struct Biotechnol J; 2020; 18():3567-3576. PubMed ID: 33304455
[TBL] [Abstract][Full Text] [Related]
8. An analysis of mutational signatures of synonymous mutations across 15 cancer types.
Bin Y; Wang X; Zhao L; Wen P; Xia J
BMC Med Genet; 2019 Dec; 20(Suppl 2):190. PubMed ID: 31815613
[TBL] [Abstract][Full Text] [Related]
9. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.
De Roock W; Claes B; Bernasconi D; De Schutter J; Biesmans B; Fountzilas G; Kalogeras KT; Kotoula V; Papamichael D; Laurent-Puig P; Penault-Llorca F; Rougier P; Vincenzi B; Santini D; Tonini G; Cappuzzo F; Frattini M; Molinari F; Saletti P; De Dosso S; Martini M; Bardelli A; Siena S; Sartore-Bianchi A; Tabernero J; Macarulla T; Di Fiore F; Gangloff AO; Ciardiello F; Pfeiffer P; Qvortrup C; Hansen TP; Van Cutsem E; Piessevaux H; Lambrechts D; Delorenzi M; Tejpar S
Lancet Oncol; 2010 Aug; 11(8):753-62. PubMed ID: 20619739
[TBL] [Abstract][Full Text] [Related]
10. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers.
Chan K; Roberts SA; Klimczak LJ; Sterling JF; Saini N; Malc EP; Kim J; Kwiatkowski DJ; Fargo DC; Mieczkowski PA; Getz G; Gordenin DA
Nat Genet; 2015 Sep; 47(9):1067-72. PubMed ID: 26258849
[TBL] [Abstract][Full Text] [Related]
11. APOBEC3A/B-induced mutagenesis is responsible for 20% of heritable mutations in the TpCpW context.
Seplyarskiy VB; Andrianova MA; Bazykin GA
Genome Res; 2017 Feb; 27(2):175-184. PubMed ID: 27940951
[TBL] [Abstract][Full Text] [Related]
12. The Number of Overlapping AID Hotspots in Germline IGHV Genes Is Inversely Correlated with Mutation Frequency in Chronic Lymphocytic Leukemia.
Yuan C; Chu CC; Yan XJ; Bagnara D; Chiorazzi N; MacCarthy T
PLoS One; 2017; 12(1):e0167602. PubMed ID: 28125682
[TBL] [Abstract][Full Text] [Related]
13. Sequence and structure signatures of cancer mutation hotspots in protein kinases.
Dixit A; Yi L; Gowthaman R; Torkamani A; Schork NJ; Verkhivker GM
PLoS One; 2009 Oct; 4(10):e7485. PubMed ID: 19834613
[TBL] [Abstract][Full Text] [Related]
14. Prospectively defined patterns of APOBEC3A mutagenesis are prevalent in human cancers.
DeWeerd RA; Németh E; Póti Á; Petryk N; Chen CL; Hyrien O; Szüts D; Green AM
Cell Rep; 2022 Mar; 38(12):110555. PubMed ID: 35320711
[TBL] [Abstract][Full Text] [Related]
15. AID Overlapping and Polη Hotspots Are Key Features of Evolutionary Variation Within the Human Antibody Heavy Chain (IGHV) Genes.
Tang C; Bagnara D; Chiorazzi N; Scharff MD; MacCarthy T
Front Immunol; 2020; 11():788. PubMed ID: 32425948
[TBL] [Abstract][Full Text] [Related]
16. Identification of coding and non-coding mutational hotspots in cancer genomes.
Piraino SW; Furney SJ
BMC Genomics; 2017 Jan; 18(1):17. PubMed ID: 28056774
[TBL] [Abstract][Full Text] [Related]
17. Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
Chang MT; Asthana S; Gao SP; Lee BH; Chapman JS; Kandoth C; Gao J; Socci ND; Solit DB; Olshen AB; Schultz N; Taylor BS
Nat Biotechnol; 2016 Feb; 34(2):155-63. PubMed ID: 26619011
[TBL] [Abstract][Full Text] [Related]
18. APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition.
Buisson R; Lawrence MS; Benes CH; Zou L
Cancer Res; 2017 Sep; 77(17):4567-4578. PubMed ID: 28698210
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial double-stranded RNA triggers induction of the antiviral DNA deaminase APOBEC3A and nuclear DNA damage.
Wick C; Moghadasi SA; Becker JT; Fanunza E; Oh S; Bournique E; Buisson R; Harris RS
J Biol Chem; 2023 Sep; 299(9):105073. PubMed ID: 37474103
[TBL] [Abstract][Full Text] [Related]
20. Correlations in Somatic Hypermutation Between Sites in IGHV Genes Can Be Explained by Interactions Between AID and/or Polη Hotspots.
Krantsevich A; Tang C; MacCarthy T
Front Immunol; 2020; 11():618409. PubMed ID: 33603748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
